Skip to main content
. Author manuscript; available in PMC: 2023 Dec 27.
Published in final edited form as: Lab Invest. 2019 Jan 18;99(5):708–721. doi: 10.1038/s41374-018-0168-7

Figure 3. Representative images comparing tissue morphology and IHC stains of Theralin fixed and formalin fixed, decalcified bone tumor samples.

Figure 3.

Patient matched tissue sections were stained with either Hematoxylin and eosin (top half) or for selected IHC targets (bottom half).